[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"radiofrequency\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:radiofrequency":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100569459","radiofrequency-and-exercise-based-rehabilitation-on-symptoms-associated-with-pelvic-floor-dysfunctions-in-breast-cancer-100569459",false,"NCT06694519","Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunctions in Breast Cancer","Effectiveness of Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunction in Breast Cancer Patients.","Inclusion Criteria:\n\n* women of legal age with a clinical history of breast cancer, who agree to participate in the study and who present pelvic dysfunction assessed by the Pelvic Floor Distress Inventory (PFDI20) ≥ 100\n* women survivors of stage 1 and 2 breast cancer\n* A medical discharge was granted more than one year ago\n* A diagnosis of another type of cancer has not been made.\n\nExclusion Criteria:\n\n* Having performed PMFT or received RF in the last 12 months\n* Use of vaginal oestrogens in the last 6 months\n* Systemic hormone therapy in the last 6 months\n* Laser therapy in the last 6 months\n* Absence of pelvic floor contraction according to the Modified Oxford Scale\n* Use of pacemaker\n* Use of heart pacemaker, decompensated heart or metabolic diseases, cognitive deficits, peripheral or central neurological disorders, previous surgeries in the pelvic region, skin pathologies or wounds in the treatment area or presence of an active urinary tract and\u002For vaginal infection.","FEMALE","18 Years",{"count":19,"type":20},117,"ESTIMATED","INTERVENTIONAL",[23],"NA","Breast cancer has a high impact, affecting 2.3 million women worldwide in 2022. In Spain, there were 40,203 new cases in 2023. In addition to the economic and social costs, patients suffer genitourinary dysfunctions due to cancer treatments. Genitourinary Menopausal Syndrome (GUS) affects 50% of menopausal women, with a higher prevalence in women with breast cancer.\n\nThis study aims to compare the effectiveness of radiofrequency (RF) and pelvic floor muscle exercise (PFMT) in the treatment of pelvic dysfunction associated with GUS in breast cancer patients. A randomised, double-blind clinical trial will be conducted in collaboration with the Association of Women Affected by Breast Cancer of Elche and Region) and the CEU Cardenal Herrera University. Women diagnosed with breast cancer and pelvic dysfunction will participate, divided into three groups: one will receive PFMT, one will receive RF and one will receive PFMT+RF therapy.\n\nBoth techniques are expected to improve the quality of life of patients, where RF could offer additional benefits due to its proven effectiveness in the treatment of vaginal dryness and dyspareunia. The expected results will contribute to more effective and less invasive treatment protocols. The project presented has the potential to positively impact the health and well-being of women with breast cancer, reducing the symptoms associated with the disease and its treatment, and improving their quality of life.",[26,27,28,29],"Breast Cancer","Genitourinary Syndrome","Radiofrequency","Physical Exercise","RECRUITING","2026-01-20",{"date":33,"type":34},"2026-01-21","ACTUAL",{"date":36,"type":34},"2025-01-30",{"date":38,"type":20},"2027-01-30",{"name":40,"class":41},"SERGIO MONTERO NAVARRO","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":16,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":4},"100585982","effect-of-capacitive-and-resistive-radiofrequency-on-postpartum-diastasis-recti-100585982","NCT06909448","Effect of Capacitive and Resistive Radiofrequency on Postpartum Diastasis Recti","Inclusion Criteria:\n\n* 1\\. Postpartum women (7 days after delivery) having diastasis recti (separation between the two recti more than 2.5cm at the level of umbilicus).\n\n  2\\. Multiparous women (2-3) times delivered vaginally with or without episiotomy.\n\n  3\\. Their age will be ranged from 20 -35 years old. 4. Their BMI will be less than 30 kg\u002Fcm2.\n\nExclusion Criteria:\n\n* Any participant will be excluded if she meets one or more of the following criteria:\n\nPostpartum women will be excluded from the study if they have:\n\n1. Abdominal or back surgery.\n2. Abdominal hernia.\n3. History of abnormal pregnancy, uterine fibroid or polyhydramnios during pregnancy.\n4. Neurological disorders as multiple sclerosis, stroke and spinal lesion.\n5. Musculoskeletal diseases such as fractures muscle strains, severe knee osteoarthritis which may affect their physical activity.","20 Years","35 Years",{"count":52,"type":20},80,[23],"To evaluate the effect of capacitive and resistive radiofrequency on postpartum rectus abdominis diastasis.",[56,28],"Diastasis Recti Abdominis (DRA)",[58],"Diastasis recti, radiofrequency therapy, physical exercises, postpartum","NOT_YET_RECRUITING","2025-03-27",{"date":62,"type":34},"2025-04-03",{"date":64,"type":20},"2025-04-06",{"date":66,"type":20},"2025-08",{"name":68,"class":41},"Cairo University"]